PCCS

Arelion and Telxius Collaborate to Expand Connectivity to North and Latin America

Retrieved on: 
Tuesday, March 12, 2024

For Telxius, it empowers customers with resilient Tier-1 optical transport and high-speed access to Arelion's North American network.

Key Points: 
  • For Telxius, it empowers customers with resilient Tier-1 optical transport and high-speed access to Arelion's North American network.
  • Together, Arelion and Telxius are making a significant investment in the Florida Peninsula to connect Latin American customers to North America through submarine and terrestrial systems.
  • The collaboration benefits both Arelion and Telxius' customers in North America and Latin America with enhanced access to the companies' global Internet backbones.
  • This network expansion complements Arelion's existing presence at Telxius' Virginia Beach landing station and further cements Arelion as a key terrestrial connectivity provider in North America.

Windstream Wholesale Brings Expansive Dark Fiber to East Coast with New ‘Beach Route’

Retrieved on: 
Monday, February 19, 2024

Windstream Wholesale, an optical technology leader in advanced network solutions, today announced a significant milestone in the construction of its new dark fiber route.

Key Points: 
  • Windstream Wholesale, an optical technology leader in advanced network solutions, today announced a significant milestone in the construction of its new dark fiber route.
  • The "Beach Route" stretches 651 route miles across a unique path down the East Coast of the United States and consists of 864-count buried fiber.
  • The Beach Route’s northern section unlocks expansive dark fiber connectivity options across major East Coast cities including from Raleigh, North Carolina, to Myrtle Beach, South Carolina, and from Myrtle Beach to Savannah, Georgia.
  • Leveraging the Windstream Wholesale industry-leading iconnect customer portal ensures reliable and efficient network tracking with dark fiber monitoring and proactive ticketing, optimizing performance and minimizing downtime.

magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases

Retrieved on: 
Wednesday, November 29, 2023

("magAssist" and "the Company"), a leading medical developer of extracorporeal life support devices in China, attended the 29th annual meeting of the International Society for Mechanical Circulatory Support (ISMCS) as a corporate member.

Key Points: 
  • ("magAssist" and "the Company"), a leading medical developer of extracorporeal life support devices in China, attended the 29th annual meeting of the International Society for Mechanical Circulatory Support (ISMCS) as a corporate member.
  • ISMCS is also a supporter of the world's first competition dedicated to artificial heart design, Heart Hackathon, which is sponsored by MedTech industry leaders including magAssist that help catalyze cardiovascular innovation.
  • During the meeting, magAssist showcased how the company's latest technological breakthroughs bridge the clinical gaps and address the unmet medical needs of patients suffering from severe heart diseases.
  • "It is an honor for magAssist to be a corporate member of ISMCS and the industry partner of Heart Hackathon that fuel transformative changes in the field.

C&W Networks Upgrades CFX-1 and EWC Submarine Cables with Ciena

Retrieved on: 
Monday, September 26, 2022

These network upgrades will help address the soaring bandwidth needs of C&W Networks telco and internet service provider (ISP) customers.

Key Points: 
  • These network upgrades will help address the soaring bandwidth needs of C&W Networks telco and internet service provider (ISP) customers.
  • C&W Networks operates the largest submarine multi-ring fiber-optic network in the greater Caribbean, Central American and Andean regions, providing reliable connectivity to approximately 40 countries.
  • C&W Networks submarine cables cross the ocean to bring the pan-Caribbean region new opportunities and economic growth through connectivity, said Ian Clarke, Vice President of Global Submarine Solutions, Ciena.
  • For updates on Ciena, follow us on Twitter @Ciena , LinkedIn , the Ciena Insights blog , or visit www.ciena.com .

Postmaster General DeJoy Addresses Nation's Commercial Mailers

Retrieved on: 
Friday, September 23, 2022

WASHINGTON, Sept. 23, 2022 /PRNewswire/ -- In a keynote video address this week to partnership groups composed of Postal Service leaders and the nation's commercial mailers, USPS Postmaster General and CEO Louis DeJoy said the Postal Service is a different organization now than when he arrived more than two years ago.

Key Points: 
  • WASHINGTON, Sept. 23, 2022 /PRNewswire/ -- In a keynote video address this week to partnership groups composed of Postal Service leaders and the nation's commercial mailers, USPS Postmaster General and CEO Louis DeJoy said the Postal Service is a different organization now than when he arrived more than two years ago.
  • DeJoy said, "One of the biggest initiatives under Delivering for America is empowering employees to embrace the changes that are needed to succeed.
  • We need your operating and marketing prowess and your competitive spirit to help us win together in the marketplace," DeJoy said.
  • The mission of the PCC is to foster a close working relationship between the Postal Service and commercial mailers.

Biocytogen Lists on the Main Board of HKEX, Aiming to Become the Headstream of New Drugs

Retrieved on: 
Thursday, September 1, 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced the companys official listing on the Main Board of the Stock Exchange of Hong Kong.

Key Points: 
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced the companys official listing on the Main Board of the Stock Exchange of Hong Kong.
  • The company harnesses these specialized models to provide preclinical pharmacology evaluation services for global pharmaceutical/biotech companies.
  • Biocytogen strives to become the headstream of novel antibody drugs.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies.

Biocytogen Lists on the Main Board of HKEX, Aiming to Become the Headstream of New Drugs

Retrieved on: 
Thursday, September 1, 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced the companys official listing on the Main Board of the Stock Exchange of Hong Kong.

Key Points: 
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced the companys official listing on the Main Board of the Stock Exchange of Hong Kong.
  • The company harnesses these specialized models to provide preclinical pharmacology evaluation services for global pharmaceutical/biotech companies.
  • Biocytogen strives to become the headstream of novel antibody drugs.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies.

Petal Maps Debuts at MWC 2022, Showcasing a Full-Scenario Ecosystem with Mapping Services as the Core

Retrieved on: 
Friday, March 4, 2022

With its leading UI design interactive experience, Petal Maps won the 2021 German Red Dot Design Award.

Key Points: 
  • With its leading UI design interactive experience, Petal Maps won the 2021 German Red Dot Design Award.
  • With this release, Petal Maps launches travel guides that include comprehensive and detailed information on Barcelona's hotels, restaurants, museums and other points of interest.
  • Petal Maps has also integrated its own mapping and positioning capabilities providing rich one-stop mapping service solutions to empower developers and partners.
  • Petal Maps plans to continue enriching the platform's capabilities, identify and integrate new cutting-edge technologies as well as collaborate with leaders in navigation technology to further perfect the mapping ecosystem and enhance the user experience.

Petal Maps Debuts at MWC 2022, Showcasing a Full-Scenario Ecosystem with Mapping Services as the Core

Retrieved on: 
Friday, March 4, 2022

Petal Maps highlights the color contrast between different regions and routes, distinguishes cities from suburbs while visually showing the differentiation in altitude between adjacent roads.

Key Points: 
  • Petal Maps highlights the color contrast between different regions and routes, distinguishes cities from suburbs while visually showing the differentiation in altitude between adjacent roads.
  • With its leading UI design interactive experience, Petal Maps won the 2021 German Red Dot Design Award.
  • With this release, Petal Maps launches travel guides that include comprehensive and detailed information on Barcelona's hotels, restaurants, museums and other points of interest.
  • Petal Maps has also integrated its own mapping and positioning capabilities providing rich one-stop mapping service solutions to empower developers and partners.

Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of Preclinical Candidate for QPCTL

Retrieved on: 
Thursday, February 17, 2022

Notably, this is the first major milestone achieved by Insilico in the strategic collaboration with Fosun Pharma.

Key Points: 
  • Notably, this is the first major milestone achieved by Insilico in the strategic collaboration with Fosun Pharma.
  • Insilico Medicine and Fosun Pharma are working together on IND-enabling studies to advance PCCs in the QPCTL program to clinical trials.
  • ISM004-1057D, Insilico's first PCC for its QPCTL program, is a potential first-in-class small molecule inhibitor that targets QPCTL.
  • As a small molecule inhibitor of QPCTL, ISM004-1057D not only provides high tumor penetration but also reduces potential hematologic and antigen sink side effects.